On December 9, 22024, the Philippines FDA announced Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration under Administrative Order No. 2024-0016.  For the past 20 years, the FDA’s fees and charges were based on Administrative Order No. 50s, 2001. However, due to recent technological advancements and the development of the health products industry, ..

On November 27, 2024, the Philippine Food and Drug Administration (FDA) issued Administrative Order No. 2024-0015, introducing updated regulation on the License to Operate (LTO) requirements for health product facilities.  This administrative order sets forth the updated rules, requirements, and procedures for the initial, renewal and change of the LTO application through the FDA eServices Porta..

The Center for Device Regulation, Radiation Health and Research (CDRRHR) of the Philippines FDA has announced that the deadline for Certificate of Medical Device Notification (CMDN) applications for non-Notified Class B, C and D Medical Devices will be extended to March 31, 2024. . (FDA Circular No. 2021-002) In the meantime, these devices may be imported and sold on the Philippines market by an..